Floriana Nappo

Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas

Antonio Pellino, Stefano Brignola, Erika Riello et al. · Journal of Personalized Medicine · 2021 · 132 citations · Full text

INFINITY: A multicentre, single-arm, multi-cohort, phase II trial of tremelimumab and durvalumab as neoadjuvant treatment of patients with microsatellite instability-high (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC/GEJAC).

Filippo Pietrantonio, Alessandra Raimondi, Sara Lonardi et al. · Journal of Clinical Oncology · 2023 · 90 citations

Surgical Oncology, Cancer Management, Immunology +22

KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target Population

Marta Schirripa, Floriana Nappo, Chiara Cremolini et al. · Clinical Colorectal Cancer · 2020 · 68 citations

Oncology, Gastrointestinal Oncology, Medicine +9

Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO

A. Raimondi, Sara Lonardi, Sabina Murgioni et al. · Annals of Oncology · 2024 · 50 citations

Surgical Oncology, Esophageal Cancer, Gastrointestinal Oncology +10

PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study

Nicola Silvestris, Antonella Argentiero, Oronzo Brunetti et al. · Expert Opinion on Therapeutic Targets · 2021 · 24 citations